Evofem Biosciences, Inc.
EVFM
$0.01
$0.0016.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.05% | -286.61% | 131.48% | -28.41% | -275.06% |
| Total Depreciation and Amortization | -12.59% | -49.25% | -17.65% | 9.86% | 600.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.35% | 108.19% | -314.42% | 183.38% | 138.77% |
| Change in Net Operating Assets | 172.13% | -133.18% | 314.19% | -492.08% | 15,875.00% |
| Cash from Operations | 111.51% | -621.25% | 123.26% | -424.62% | 59.77% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -23.91% | 90.96% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 96.49% | -23.91% | 90.96% | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | 1.61% | -83.70% | 49.44% | -1.91% | -3.56% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -109.53% | 1,996.30% | -105.46% | 147.80% | -12.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.48% | -198.10% | 1,836.84% | -36.67% | 900.00% |